カテゴリー： 世界, 部品/材料, LP Information

世界のトシル酸ソラフェニブAPI市場予測 2023年-2029年

【英語タイトル】Global Sorafenib Tosylate API Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10778）・商品コード：LP23DC10778
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のトシル酸ソラフェニブAPI市場」は、過去の販売実績から2022年の世界のトシル酸ソラフェニブAPIの総販売量を検討し、2023年から2029年の予測されるトシル酸ソラフェニブAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のトシル酸ソラフェニブAPIの市場規模を掲載し、XXX百万米ドル規模の世界のトシル酸ソラフェニブAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のトシル酸ソラフェニブAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のトシル酸ソラフェニブAPI市場における各社の独自のポジションをより深く理解するために、トシル酸ソラフェニブAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のトシル酸ソラフェニブAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。トシル酸ソラフェニブAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。トシル酸ソラフェニブAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。トシル酸ソラフェニブAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

トシル酸ソラフェニブAPIの世界主要メーカーとしては、Teva API、 Natco Pharma、 Cipla、 Alembic Pharmaceutical、 Hetero、 Aurobindo Pharma、 Sun Pharmaceutical Industries、 BDR Lifesciences、 Delmar Chemicals、 Yabao Pharmaceutical Group、 Sichuan Xieli Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のトシル酸ソラフェニブAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではトシル酸ソラフェニブAPI市場をセグメンテーションし、種類別 (フォームⅠ、フォームⅢ)、用途別 (製薬、科学研究、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：フォームⅠ、フォームⅢ

・用途別区分：製薬、科学研究、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のトシル酸ソラフェニブAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たトシル酸ソラフェニブAPI市場成長の要因は何か？
・トシル酸ソラフェニブAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・トシル酸ソラフェニブAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：トシル酸ソラフェニブAPIの年間販売量2018-2029、地域別現状・将来分析
・トシル酸ソラフェニブAPIの種類別セグメント：フォームⅠ、フォームⅢ
・トシル酸ソラフェニブAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・トシル酸ソラフェニブAPIの用途別セグメント：製薬、科学研究、その他
・トシル酸ソラフェニブAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のトシル酸ソラフェニブAPI市場
・企業別のグローバルトシル酸ソラフェニブAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のトシル酸ソラフェニブAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のトシル酸ソラフェニブAPI販売価格
・主要企業のトシル酸ソラフェニブAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

トシル酸ソラフェニブAPIの地域別レビュー
・地域別のトシル酸ソラフェニブAPI市場規模2018-2023：年間販売量、売上
・主要国別のトシル酸ソラフェニブAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのトシル酸ソラフェニブAPI販売の成長
・アジア太平洋のトシル酸ソラフェニブAPI販売の成長
・ヨーロッパのトシル酸ソラフェニブAPI販売の成長
・中東・アフリカのトシル酸ソラフェニブAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のトシル酸ソラフェニブAPI販売量、売上（2018-2023）
・南北アメリカのトシル酸ソラフェニブAPIの種類別販売量
・南北アメリカのトシル酸ソラフェニブAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のトシル酸ソラフェニブAPI販売量、売上（2018-2023）
・アジア太平洋のトシル酸ソラフェニブAPIの種類別販売量
・アジア太平洋のトシル酸ソラフェニブAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のトシル酸ソラフェニブAPI販売量、売上（2018-2023）
・ヨーロッパのトシル酸ソラフェニブAPIの種類別販売量
・ヨーロッパのトシル酸ソラフェニブAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のトシル酸ソラフェニブAPI販売量、売上（2018-2023）
・中東・アフリカのトシル酸ソラフェニブAPIの種類別販売量
・中東・アフリカのトシル酸ソラフェニブAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・トシル酸ソラフェニブAPIの製造コスト構造分析
・トシル酸ソラフェニブAPIの製造プロセス分析
・トシル酸ソラフェニブAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・トシル酸ソラフェニブAPIの主要なグローバル販売業者
・トシル酸ソラフェニブAPIの主要なグローバル顧客

地域別のトシル酸ソラフェニブAPI市場予測レビュー
・地域別のトシル酸ソラフェニブAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・トシル酸ソラフェニブAPIの種類別市場規模予測
・トシル酸ソラフェニブAPIの用途別市場規模予測

主要企業分析
Teva API、 Natco Pharma、 Cipla、 Alembic Pharmaceutical、 Hetero、 Aurobindo Pharma、 Sun Pharmaceutical Industries、 BDR Lifesciences、 Delmar Chemicals、 Yabao Pharmaceutical Group、 Sichuan Xieli Pharmaceutical
・企業情報
・トシル酸ソラフェニブAPI製品
・トシル酸ソラフェニブAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Sorafenib Tosylate API market size is projected to grow from US$ 34 million in 2022 to US$ 52 million in 2029; it is expected to grow at a CAGR of 6.0% from 2023 to 2029.
United States market for Sorafenib Tosylate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sorafenib Tosylate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sorafenib Tosylate API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sorafenib Tosylate API players cover Teva API, Natco Pharma, Cipla, Alembic Pharmaceutical, Hetero, Aurobindo Pharma, Sun Pharmaceutical Industries, BDR Lifesciences and Delmar Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division.
LPI (LP Information)’ newest research report, the “Sorafenib Tosylate API Industry Forecast” looks at past sales and reviews total world Sorafenib Tosylate API sales in 2022, providing a comprehensive analysis by region and market sector of projected Sorafenib Tosylate API sales for 2023 through 2029. With Sorafenib Tosylate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sorafenib Tosylate API industry.
This Insight Report provides a comprehensive analysis of the global Sorafenib Tosylate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sorafenib Tosylate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sorafenib Tosylate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sorafenib Tosylate API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sorafenib Tosylate API.
This report presents a comprehensive overview, market shares, and growth opportunities of Sorafenib Tosylate API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
FormⅠ
Form Ⅲ
Segmentation by application
Pharmaceutical
Scientific Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Teva API
Natco Pharma
Cipla
Alembic Pharmaceutical
Hetero
Aurobindo Pharma
Sun Pharmaceutical Industries
BDR Lifesciences
Delmar Chemicals
Yabao Pharmaceutical Group
Sichuan Xieli Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sorafenib Tosylate API market?
What factors are driving Sorafenib Tosylate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sorafenib Tosylate API market opportunities vary by end market size?
How does Sorafenib Tosylate API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sorafenib Tosylate API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sorafenib Tosylate API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sorafenib Tosylate API by Country/Region, 2018, 2022 & 2029
2.2 Sorafenib Tosylate API Segment by Type
2.2.1 FormⅠ
2.2.2 Form Ⅲ
2.3 Sorafenib Tosylate API Sales by Type
2.3.1 Global Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
2.3.2 Global Sorafenib Tosylate API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sorafenib Tosylate API Sale Price by Type (2018-2023)
2.4 Sorafenib Tosylate API Segment by Application
2.4.1 Pharmaceutical
2.4.2 Scientific Research
2.4.3 Other
2.5 Sorafenib Tosylate API Sales by Application
2.5.1 Global Sorafenib Tosylate API Sale Market Share by Application (2018-2023)
2.5.2 Global Sorafenib Tosylate API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sorafenib Tosylate API Sale Price by Application (2018-2023)
3 Global Sorafenib Tosylate API by Company
3.1 Global Sorafenib Tosylate API Breakdown Data by Company
3.1.1 Global Sorafenib Tosylate API Annual Sales by Company (2018-2023)
3.1.2 Global Sorafenib Tosylate API Sales Market Share by Company (2018-2023)
3.2 Global Sorafenib Tosylate API Annual Revenue by Company (2018-2023)
3.2.1 Global Sorafenib Tosylate API Revenue by Company (2018-2023)
3.2.2 Global Sorafenib Tosylate API Revenue Market Share by Company (2018-2023)
3.3 Global Sorafenib Tosylate API Sale Price by Company
3.4 Key Manufacturers Sorafenib Tosylate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sorafenib Tosylate API Product Location Distribution
3.4.2 Players Sorafenib Tosylate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sorafenib Tosylate API by Geographic Region
4.1 World Historic Sorafenib Tosylate API Market Size by Geographic Region (2018-2023)
4.1.1 Global Sorafenib Tosylate API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sorafenib Tosylate API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sorafenib Tosylate API Market Size by Country/Region (2018-2023)
4.2.1 Global Sorafenib Tosylate API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sorafenib Tosylate API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sorafenib Tosylate API Sales Growth
4.4 APAC Sorafenib Tosylate API Sales Growth
4.5 Europe Sorafenib Tosylate API Sales Growth
4.6 Middle East & Africa Sorafenib Tosylate API Sales Growth
5 Americas
5.1 Americas Sorafenib Tosylate API Sales by Country
5.1.1 Americas Sorafenib Tosylate API Sales by Country (2018-2023)
5.1.2 Americas Sorafenib Tosylate API Revenue by Country (2018-2023)
5.2 Americas Sorafenib Tosylate API Sales by Type
5.3 Americas Sorafenib Tosylate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sorafenib Tosylate API Sales by Region
6.1.1 APAC Sorafenib Tosylate API Sales by Region (2018-2023)
6.1.2 APAC Sorafenib Tosylate API Revenue by Region (2018-2023)
6.2 APAC Sorafenib Tosylate API Sales by Type
6.3 APAC Sorafenib Tosylate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sorafenib Tosylate API by Country
7.1.1 Europe Sorafenib Tosylate API Sales by Country (2018-2023)
7.1.2 Europe Sorafenib Tosylate API Revenue by Country (2018-2023)
7.2 Europe Sorafenib Tosylate API Sales by Type
7.3 Europe Sorafenib Tosylate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sorafenib Tosylate API by Country
8.1.1 Middle East & Africa Sorafenib Tosylate API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sorafenib Tosylate API Revenue by Country (2018-2023)
8.2 Middle East & Africa Sorafenib Tosylate API Sales by Type
8.3 Middle East & Africa Sorafenib Tosylate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sorafenib Tosylate API
10.3 Manufacturing Process Analysis of Sorafenib Tosylate API
10.4 Industry Chain Structure of Sorafenib Tosylate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sorafenib Tosylate API Distributors
11.3 Sorafenib Tosylate API Customer
12 World Forecast Review for Sorafenib Tosylate API by Geographic Region
12.1 Global Sorafenib Tosylate API Market Size Forecast by Region
12.1.1 Global Sorafenib Tosylate API Forecast by Region (2024-2029)
12.1.2 Global Sorafenib Tosylate API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sorafenib Tosylate API Forecast by Type
12.7 Global Sorafenib Tosylate API Forecast by Application
13 Key Players Analysis
13.1 Teva API
13.1.1 Teva API Company Information
13.1.2 Teva API Sorafenib Tosylate API Product Portfolios and Specifications
13.1.3 Teva API Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva API Main Business Overview
13.1.5 Teva API Latest Developments
13.2 Natco Pharma
13.2.1 Natco Pharma Company Information
13.2.2 Natco Pharma Sorafenib Tosylate API Product Portfolios and Specifications
13.2.3 Natco Pharma Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Natco Pharma Main Business Overview
13.2.5 Natco Pharma Latest Developments
13.3 Cipla
13.3.1 Cipla Company Information
13.3.2 Cipla Sorafenib Tosylate API Product Portfolios and Specifications
13.3.3 Cipla Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cipla Main Business Overview
13.3.5 Cipla Latest Developments
13.4 Alembic Pharmaceutical
13.4.1 Alembic Pharmaceutical Company Information
13.4.2 Alembic Pharmaceutical Sorafenib Tosylate API Product Portfolios and Specifications
13.4.3 Alembic Pharmaceutical Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alembic Pharmaceutical Main Business Overview
13.4.5 Alembic Pharmaceutical Latest Developments
13.5 Hetero
13.5.1 Hetero Company Information
13.5.2 Hetero Sorafenib Tosylate API Product Portfolios and Specifications
13.5.3 Hetero Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hetero Main Business Overview
13.5.5 Hetero Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Sorafenib Tosylate API Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 Sun Pharmaceutical Industries
13.7.1 Sun Pharmaceutical Industries Company Information
13.7.2 Sun Pharmaceutical Industries Sorafenib Tosylate API Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Industries Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sun Pharmaceutical Industries Main Business Overview
13.7.5 Sun Pharmaceutical Industries Latest Developments
13.8 BDR Lifesciences
13.8.1 BDR Lifesciences Company Information
13.8.2 BDR Lifesciences Sorafenib Tosylate API Product Portfolios and Specifications
13.8.3 BDR Lifesciences Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BDR Lifesciences Main Business Overview
13.8.5 BDR Lifesciences Latest Developments
13.9 Delmar Chemicals
13.9.1 Delmar Chemicals Company Information
13.9.2 Delmar Chemicals Sorafenib Tosylate API Product Portfolios and Specifications
13.9.3 Delmar Chemicals Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Delmar Chemicals Main Business Overview
13.9.5 Delmar Chemicals Latest Developments
13.10 Yabao Pharmaceutical Group
13.10.1 Yabao Pharmaceutical Group Company Information
13.10.2 Yabao Pharmaceutical Group Sorafenib Tosylate API Product Portfolios and Specifications
13.10.3 Yabao Pharmaceutical Group Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Yabao Pharmaceutical Group Main Business Overview
13.10.5 Yabao Pharmaceutical Group Latest Developments
13.11 Sichuan Xieli Pharmaceutical
13.11.1 Sichuan Xieli Pharmaceutical Company Information
13.11.2 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product Portfolios and Specifications
13.11.3 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan Xieli Pharmaceutical Main Business Overview
13.11.5 Sichuan Xieli Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Sorafenib Tosylate API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sorafenib Tosylate API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of FormⅠ
Table 4. Major Players of Form Ⅲ
Table 5. Global Sorafenib Tosylate API Sales by Type (2018-2023) & (Tons)
Table 6. Global Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
Table 7. Global Sorafenib Tosylate API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sorafenib Tosylate API Revenue Market Share by Type (2018-2023)
Table 9. Global Sorafenib Tosylate API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Sorafenib Tosylate API Sales by Application (2018-2023) & (Tons)
Table 11. Global Sorafenib Tosylate API Sales Market Share by Application (2018-2023)
Table 12. Global Sorafenib Tosylate API Revenue by Application (2018-2023)
Table 13. Global Sorafenib Tosylate API Revenue Market Share by Application (2018-2023)
Table 14. Global Sorafenib Tosylate API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Sorafenib Tosylate API Sales by Company (2018-2023) & (Tons)
Table 16. Global Sorafenib Tosylate API Sales Market Share by Company (2018-2023)
Table 17. Global Sorafenib Tosylate API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sorafenib Tosylate API Revenue Market Share by Company (2018-2023)
Table 19. Global Sorafenib Tosylate API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Sorafenib Tosylate API Producing Area Distribution and Sales Area
Table 21. Players Sorafenib Tosylate API Products Offered
Table 22. Sorafenib Tosylate API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sorafenib Tosylate API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Sorafenib Tosylate API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sorafenib Tosylate API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sorafenib Tosylate API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sorafenib Tosylate API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Sorafenib Tosylate API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sorafenib Tosylate API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sorafenib Tosylate API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sorafenib Tosylate API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Sorafenib Tosylate API Sales Market Share by Country (2018-2023)
Table 35. Americas Sorafenib Tosylate API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sorafenib Tosylate API Revenue Market Share by Country (2018-2023)
Table 37. Americas Sorafenib Tosylate API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Sorafenib Tosylate API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Sorafenib Tosylate API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Sorafenib Tosylate API Sales Market Share by Region (2018-2023)
Table 41. APAC Sorafenib Tosylate API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sorafenib Tosylate API Revenue Market Share by Region (2018-2023)
Table 43. APAC Sorafenib Tosylate API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Sorafenib Tosylate API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Sorafenib Tosylate API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Sorafenib Tosylate API Sales Market Share by Country (2018-2023)
Table 47. Europe Sorafenib Tosylate API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sorafenib Tosylate API Revenue Market Share by Country (2018-2023)
Table 49. Europe Sorafenib Tosylate API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Sorafenib Tosylate API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Sorafenib Tosylate API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Sorafenib Tosylate API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sorafenib Tosylate API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sorafenib Tosylate API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sorafenib Tosylate API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Sorafenib Tosylate API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Sorafenib Tosylate API
Table 58. Key Market Challenges & Risks of Sorafenib Tosylate API
Table 59. Key Industry Trends of Sorafenib Tosylate API
Table 60. Sorafenib Tosylate API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sorafenib Tosylate API Distributors List
Table 63. Sorafenib Tosylate API Customer List
Table 64. Global Sorafenib Tosylate API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Sorafenib Tosylate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sorafenib Tosylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Sorafenib Tosylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sorafenib Tosylate API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Sorafenib Tosylate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sorafenib Tosylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Sorafenib Tosylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sorafenib Tosylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Sorafenib Tosylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sorafenib Tosylate API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Sorafenib Tosylate API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sorafenib Tosylate API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Sorafenib Tosylate API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva API Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva API Sorafenib Tosylate API Product Portfolios and Specifications
Table 80. Teva API Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Teva API Main Business
Table 82. Teva API Latest Developments
Table 83. Natco Pharma Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 84. Natco Pharma Sorafenib Tosylate API Product Portfolios and Specifications
Table 85. Natco Pharma Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Natco Pharma Main Business
Table 87. Natco Pharma Latest Developments
Table 88. Cipla Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 89. Cipla Sorafenib Tosylate API Product Portfolios and Specifications
Table 90. Cipla Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Cipla Main Business
Table 92. Cipla Latest Developments
Table 93. Alembic Pharmaceutical Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 94. Alembic Pharmaceutical Sorafenib Tosylate API Product Portfolios and Specifications
Table 95. Alembic Pharmaceutical Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Alembic Pharmaceutical Main Business
Table 97. Alembic Pharmaceutical Latest Developments
Table 98. Hetero Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 99. Hetero Sorafenib Tosylate API Product Portfolios and Specifications
Table 100. Hetero Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Hetero Main Business
Table 102. Hetero Latest Developments
Table 103. Aurobindo Pharma Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Sorafenib Tosylate API Product Portfolios and Specifications
Table 105. Aurobindo Pharma Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Sun Pharmaceutical Industries Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Industries Sorafenib Tosylate API Product Portfolios and Specifications
Table 110. Sun Pharmaceutical Industries Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Sun Pharmaceutical Industries Main Business
Table 112. Sun Pharmaceutical Industries Latest Developments
Table 113. BDR Lifesciences Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 114. BDR Lifesciences Sorafenib Tosylate API Product Portfolios and Specifications
Table 115. BDR Lifesciences Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. BDR Lifesciences Main Business
Table 117. BDR Lifesciences Latest Developments
Table 118. Delmar Chemicals Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 119. Delmar Chemicals Sorafenib Tosylate API Product Portfolios and Specifications
Table 120. Delmar Chemicals Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Delmar Chemicals Main Business
Table 122. Delmar Chemicals Latest Developments
Table 123. Yabao Pharmaceutical Group Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 124. Yabao Pharmaceutical Group Sorafenib Tosylate API Product Portfolios and Specifications
Table 125. Yabao Pharmaceutical Group Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Yabao Pharmaceutical Group Main Business
Table 127. Yabao Pharmaceutical Group Latest Developments
Table 128. Sichuan Xieli Pharmaceutical Basic Information, Sorafenib Tosylate API Manufacturing Base, Sales Area and Its Competitors
Table 129. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product Portfolios and Specifications
Table 130. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Sichuan Xieli Pharmaceutical Main Business
Table 132. Sichuan Xieli Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Sorafenib Tosylate API
Figure 2. Sorafenib Tosylate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sorafenib Tosylate API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Sorafenib Tosylate API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sorafenib Tosylate API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of FormⅠ
Figure 10. Product Picture of Form Ⅲ
Figure 11. Global Sorafenib Tosylate API Sales Market Share by Type in 2022
Figure 12. Global Sorafenib Tosylate API Revenue Market Share by Type (2018-2023)
Figure 13. Sorafenib Tosylate API Consumed in Pharmaceutical
Figure 14. Global Sorafenib Tosylate API Market: Pharmaceutical (2018-2023) & (Tons)
Figure 15. Sorafenib Tosylate API Consumed in Scientific Research
Figure 16. Global Sorafenib Tosylate API Market: Scientific Research (2018-2023) & (Tons)
Figure 17. Sorafenib Tosylate API Consumed in Other
Figure 18. Global Sorafenib Tosylate API Market: Other (2018-2023) & (Tons)
Figure 19. Global Sorafenib Tosylate API Sales Market Share by Application (2022)
Figure 20. Global Sorafenib Tosylate API Revenue Market Share by Application in 2022
Figure 21. Sorafenib Tosylate API Sales Market by Company in 2022 (Tons)
Figure 22. Global Sorafenib Tosylate API Sales Market Share by Company in 2022
Figure 23. Sorafenib Tosylate API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Sorafenib Tosylate API Revenue Market Share by Company in 2022
Figure 25. Global Sorafenib Tosylate API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Sorafenib Tosylate API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Sorafenib Tosylate API Sales 2018-2023 (Tons)
Figure 28. Americas Sorafenib Tosylate API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Sorafenib Tosylate API Sales 2018-2023 (Tons)
Figure 30. APAC Sorafenib Tosylate API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Sorafenib Tosylate API Sales 2018-2023 (Tons)
Figure 32. Europe Sorafenib Tosylate API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Sorafenib Tosylate API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Sorafenib Tosylate API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Sorafenib Tosylate API Sales Market Share by Country in 2022
Figure 36. Americas Sorafenib Tosylate API Revenue Market Share by Country in 2022
Figure 37. Americas Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
Figure 38. Americas Sorafenib Tosylate API Sales Market Share by Application (2018-2023)
Figure 39. United States Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Sorafenib Tosylate API Sales Market Share by Region in 2022
Figure 44. APAC Sorafenib Tosylate API Revenue Market Share by Regions in 2022
Figure 45. APAC Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
Figure 46. APAC Sorafenib Tosylate API Sales Market Share by Application (2018-2023)
Figure 47. China Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Sorafenib Tosylate API Sales Market Share by Country in 2022
Figure 55. Europe Sorafenib Tosylate API Revenue Market Share by Country in 2022
Figure 56. Europe Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
Figure 57. Europe Sorafenib Tosylate API Sales Market Share by Application (2018-2023)
Figure 58. Germany Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Sorafenib Tosylate API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Sorafenib Tosylate API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Sorafenib Tosylate API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Sorafenib Tosylate API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Sorafenib Tosylate API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Sorafenib Tosylate API in 2022
Figure 73. Manufacturing Process Analysis of Sorafenib Tosylate API
Figure 74. Industry Chain Structure of Sorafenib Tosylate API
Figure 75. Channels of Distribution
Figure 76. Global Sorafenib Tosylate API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Sorafenib Tosylate API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Sorafenib Tosylate API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Sorafenib Tosylate API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Sorafenib Tosylate API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Sorafenib Tosylate API Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のトシル酸ソラフェニブAPI市場予測 2023年-2029年] (コード：LP23DC10778)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトシル酸ソラフェニブAPI市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品用イブルチニブ市場予測 2023年-2029年
  • 世界の医薬品用硫酸カルシウム市場予測 2023年-2029年
  • 世界の医薬品用水酸化ナトリウム市場予測 2023年-2029年
  • 世界の医薬品用アプレミラスト市場予測 2023年-2029年
  • 世界の医薬品用アパルタミド市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆